-
- SARS-CoV-2
May 19, 2023Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants -
- SARS-CoV-2
May 15, 2023Unraveling part of the evolutionary pattern of the SARS-CoV-2 Omicron strain -
- PD-L1
Mar 20, 2023Enhancement of Vaccine-Induced T-Cell Responses by PD-L1 Blockade in Calves -
- COVID-19
Dec 08, 2022Collaboration with Shionogi for drug discovery – the first domestically produced COVID-19 treatment, Xocova was approved
